Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06284408 · ClinicalTrials.gov registry record · NA
Centralized Screening Unit (CSU) at Montefiore-Einstein
A NA study of Lung Cancer, sponsored by Albert Einstein College of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 9,460
- Enrollment target
- 1
- Study location
NCT06284408: Recruiting NA study of Lung Cancer, sponsored by Albert Einstein College of Medicine.
NCT06284408 is a NA study of Lung Cancer that is actively recruiting participants, run by Albert Einstein College of Medicine. The registered enrollment target is 9,460 participants, above the 913-participant average among 409 other Lung Cancer trials with a reported enrollment target (936% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06284408, a NA study of Lung Cancer, is actively recruiting participants, sponsored by Albert Einstein College of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 9,460 participants
- Enrollment target
- 1
- Study location
Study Summary
This study proposes to increase Lung-cancer screening (LCS) in the Bronx, New York. Despite strong evidence that Lung-cancer screening (LCS) can reduce Lung cancer (LCa) deaths, low-dose computed tomography (LDCT) referral rates by clinicians are very low and there is poor adherence with LCS by patients. Both provider and patient barriers may be amenable to systemic improvements in support, coordination and infrastructure for screening. The investigator team hypothesizes that the implementation of a Central Screening Unit (CSU) that shifts routine workflow attributed to LCS (e.g., collection of smoking history, determination of eligibility, shared decision making and arranging follow-up) away from busy practices (usual care) and that offers patients an array of navigation and support services will increase the uptake of LCS guidelines and subsequent low-dose computed tomography (LDCT) screening scans in a low-income, predominately Hispanic and Black catchment area. The proposed study represents a unique opportunity to test this hypothesis in the context of the roll out of a CSU as a significant new component of the Montefiore-Einstein health system. The investigator team will examine whether and how the CSU facilitates LCS uptake and retention of patients. This study is powered to test whether CSU reduces proportion of late-stage lung cancer diagnoses in the Bronx, New York.
Primary Outcome
The number of participant referrals by clinician for LCS by the CSU versus the number of clinician referrals will be assessed and reported.
Conditions Studied
Interventions
- OTHER Centralized Screening Unit Implementation
Study Locations (1)
New York
- Montefiore Medical Center's New York City Research and Improvement Networking Group (NYC RING) - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,460 participants |
| Start Date | 2025-02-24 |
| Est. Completion | 2029-06 |
| Phase | NA |
What NCT06284408 shows while recruiting
NCT06284408 is an interventional study that assigns participants to a tested intervention. Its 9,460 participants enrollment target places it among the larger protocols in the corpus, above the 913-participant average among 409 other Lung Cancer trials with a reported enrollment target (936% higher).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Centralized Screening Unit Implementation is the first listed.
NCT06284408 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06284408 about?
NCT06284408 is a clinical study titled "Centralized Screening Unit (CSU) at Montefiore-Einstein". This study proposes to increase Lung-cancer screening (LCS) in the Bronx, New York. Despite strong evidence that Lung-cancer screening (LCS) can reduce Lung cancer (LCa) deaths, low-dose computed tomography (LDCT) referral rates by clinicians are very low and there is poor adherence with LCS by pati...
What is the current status of trial NCT06284408?
This trial is currently recruiting. It is a NA study. The enrollment target is 9,460 participants. The study started on 2025-02-24. Estimated completion is 2029-06.
What conditions does trial NCT06284408 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT06284408?
The interventions under investigation include: Centralized Screening Unit Implementation (OTHER).
Who is sponsoring clinical trial NCT06284408?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06284408 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06284408's enrollment target sits among peer trials
9,460 11th of 409 higher than 399 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05080673 · 9,500 participants · NA
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- NCT06946355 · 9,119 participants · NA
Food-based Support for Hospitalized Children and Their Families
- NCT02000089 · 9,000 participants · Phase 3
The Cancer of the Pancreas Screening-5 CAPS5)Study
- NCT05612347 · 8,946 participants · NA
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI